Pancreatic Cancer Research

ResearcherZhengzhou UniversityActive in the last 2 years

Kai Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7154-5057; OpenAlex author ID A5100323892. Sources: OpenAlex.

Their work

Papers
11 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
35
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: 4 papers · 2022: 2 papers · 2023: 2 papers · 2024: 1 paper

Papers 11

  1. [Short-term outcomes of the TRIANGLE operation after neoadjuvant chemotherapy in locally advanced pancreatic cancer]. Co-author DOI 10.3760/cma.j.cn112139-20230615-000234↗
  2. Diagnostic value of multi-slice spiral CT and MRI in peripheral lymph node metastasis of pancreatic cancer. First author DOI 10.1016/j.asjsur.2022.11.034↗
  3. Comprehensive prognostic and immune analysis of a glycosylation related risk model in pancreatic cancer. Co-author DOI 10.1186/s12885-023-11725-1↗
  4. Incidence of Pancreatic Cancer by Age and Sex in the US From 2000 to 2018. First author DOI 10.1001/jama.2022.2312↗
  5. Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China. Co-author DOI 10.1001/jamanetworkopen.2021.48721↗
  6. Survival prediction after upfront surgery in patients with pancreatic ductal adenocarcinoma: Radiomic, clinic-pathologic and body composition analysis. Co-author DOI 10.1016/j.pan.2021.02.009↗
  7. Prognostic impact of the ratio of preoperative CA19-9 to liver enzyme levels in pancreatic cancer patients with jaundice (predictability of combined CA19-9/AST… Co-author DOI 10.1016/j.pan.2021.05.300↗
  8. Development and validation of a ferroptosis-related prognostic model in pancreatic cancer Co-author DOI 10.21203/rs.3.rs-139597/v2↗
  9. CA9-Related Acidic Microenvironment Mediates CD8+ T Cell Related Immunosuppression in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2021.832315↗
  10. Expression patterns and prognostic values of the cyclin-dependent kinase 1 and cyclin A2 gene cluster in pancreatic adenocarcinoma. Last author DOI 10.1177/0300060520930113↗
  11. Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study. Co-author DOI 10.1007/s00423-019-01766-1↗

Closest collaborators

The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kuirong Jiang · 8 shared papers, 2019–2024 · strength 1.09
  2. Yi Miao · 6 shared papers, 2019–2024 · strength 0.89
  3. Min Tu · 4 shared papers, 2021–2024 · strength 0.55
  4. Zipeng Lu · 4 shared papers, 2021–2022 · strength 0.51
  5. Jishu Wei · 4 shared papers, 2019–2024 · strength 0.50
  6. Wentao Gao · 4 shared papers, 2019–2022 · strength 0.45
  7. Chunhua Xi · 3 shared papers, 2021–2024 · strength 0.41
  8. Baobao Cai · 2 shared papers, 2021–2022 · strength 0.39
  9. Lingdi Yin · 3 shared papers, 2019–2022 · strength 0.32
  10. Junli Wu · 3 shared papers, 2019–2022 · strength 0.32
  11. Pengfei Wu · 2 shared papers, 2021–2024 · strength 0.31
  12. Nan Lyu · 2 shared papers, 2019–2024 · strength 0.26
  13. Bingsen Wang · 1 shared paper, 2023 · strength 0.26
  14. Yuechao Ding · 1 shared paper, 2023 · strength 0.26
  15. Tao Huang · 1 shared paper, 2023 · strength 0.26
  16. Qiang Li · 2 shared papers, 2021–2022 · strength 0.23
  17. Guangfu Wang · 2 shared papers, 2019–2021 · strength 0.22
  18. Hao Gao · 2 shared papers, 2019–2022 · strength 0.21
  19. Yunpeng Peng · 2 shared papers, 2019–2021 · strength 0.19
  20. Jiangtao Yin · 1 shared paper, 2024 · strength 0.18
  21. Yang Feng Wu · 1 shared paper, 2024 · strength 0.18
  22. Di Xu · 1 shared paper, 2024 · strength 0.18
  23. Xue-Ang Liu · 1 shared paper, 2023 · strength 0.18
  24. Hao Yuan · 1 shared paper, 2023 · strength 0.18
  25. Jian Shi · 1 shared paper, 2023 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.